PLUS THERAPEUTICS, INC.·4

Aug 15, 4:29 PM ET

HEDRICK MARC H 4

4 · PLUS THERAPEUTICS, INC. · Filed Aug 15, 2025

Insider Transaction Report

Form 4
Period: 2025-08-13
HEDRICK MARC H
DirectorChief Executive Officer
Transactions
  • Award

    Restricted Stock Units

    2025-08-13+1,916,1681,916,168 total
    Common Stock (1,916,168 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-08-13+5,748,5065,748,506 total
    Exercise: $0.57Exp: 2035-08-12Common Stock (5,748,506 underlying)
Footnotes (2)
  • [F1]The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.
  • [F2]The Restricted Stock Units (RSUs) awarded on August 13, 2025 vest over three years, with 1/3rd vesting on the first anniversary of the Grant Date and the remaining 2/3rds vesting in equal monthly installments over the following two years. The RUSs convert into shares of Common Stock upon vesting on a one for one basis.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4